Thursday 19 May 2022 - 04:43
In Business 42 Years - Since 1980
Reminder: Genuine LC Laboratories® brand PMA, which we have been manufacturing in the U.S. for more
than 40 years, is available directly from us: Cat No. P-1680 Phorbol 12-Myristate 13-Acetate, >99.5%.
Our PMA is also available from our >50 U.S. and international distributors, and from more than a dozen
major biochemical reagent "resellers" (who sell our PMA under their own brand names and labels)
FREE SHIPPING TO THE U.S. AND 32 OTHER COUNTRIES! [Read more].
N-9055 Nintedanib, Ethanesulfonate Salt, >99%
Synonyms : [BIBF1120 Esylate] [Intedanib Esylate] [Nintedanib Esylate]
Related Terms : [OFEV] [Vargatef]
- Size
- US $
- €
- £
- ¥
- 25 mg
- 38
- 36
- 30
- 4,900
- In stock
- 50 mg
- 49
- 46
- 39
- 6,300
- In stock
- 100 mg
- 64
- 60
- 51
- 8,300
- In stock
- 200 mg
- 85
- 80
- 68
- 11,000
- In stock
- 500 mg
- 144
- 136
- 116
- 18,600
- In stock
- 1 g
- 199
- 189
- 160
- 25,700
- In stock
- 2 g
- 346
- 329
- 278
- 44,700
- In stock
- 5 g
- 690
- 656
- 556
- 89,200
- In stock
- 10 g
- 1,160
- 1,103
- 934
- 150,000
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
- M.W. 649.76
- C31H33N5O4•C2H6O3S
- [656247-18-6]
- M.I. 15: 5031
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 25 mg/mL with warming; soluble in ethanol at 8 mg/mL with warming; soluble in water at 25 mg/mL with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.
- This research compound is the ethanesulfonate salt form of nintedanib; please see the other form of this product, Nintedanib, Free Base, Cat. No. N-9077, for further technical information about both of these research compounds.
- This nintedanib product is the ethanesulfonate salt, whose CAS number is given above. The CAS number of the Nintedanib, Free Base form is 656247-17-5.
- Nintedanib Ethanesulfonate Salt is the active ingredient in the drug product sold under the trade name Vargatef®. This drug has been used in human clinical trials for patients with non-small cell lung, colorectal, uterine, endometrial, ovarian, and cervical cancer and multiple myeloma. NOTE: THE NINTEDANIB, ETHANESULFONATE SALT SOLD BY LC LABORATORIES FOR RESEARCH IS NOT VARGATEF®, AND IS NOT FOR HUMAN USE.
- Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
